Fesoterodine Fumarate Extended-Release Tablets Articles
Research results for Pfizer's Chantix, Pristiq and Toviaz
27 January 2013
Positive Ph IV data for Pfizer and UCB's Toviaz
6 August 2012
FDA eyes orlistat for potential liver problems, Chantix under scrutiny for skin reaction
5 June 2009
US FDA approves Pfizer's Toviaz
10 November 2008
Pfizer's Toviaz launches in UK
1 September 2008
Pfizer launches Toviaz in UK
23 June 2008
Showing 1-6 of 6 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Is the diabetes market facing a blockbuster-free future?
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
